Status:
UNKNOWN
Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis
Lead Sponsor:
Herlev Hospital
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
PHASE2
Brief Summary
Treatment with PPARgamma ligands have been shown to reduces intestinal inflammation in murine models of colitis. The aim of this study was to evaluate the effect of treatment with local PPARgamma liga...
Eligibility Criteria
Inclusion
- Distal ulcerative colitis (Mayo Clinical Score \> 7)
- Age \> 18 years
- Written consent
Exclusion
- Age \< 18 years
- Severe ulcerative colitis
- Systemic treatment with steroids or azathioprin within the last 3 month
- Known liver or kidney disease
- Severe heart failure
- Pregnancy or breast feeding
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
End Date :
June 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00309660
Start Date
November 1 2005
End Date
June 1 2007
Last Update
September 21 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. Gastroenterology C, Herlev University Hospital
Herlev, Denmark, 2730